John Snisarenko is CCO at Oyster Point Pharma, Inc. (OYST). They have made 3 open-market trades across 2 companies since 2019, most recently 2024-09-16.
CIK 0001783264
3 open-market purchases totalling $201K since 2019, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.